Trials / Sponsors / Rondo Therapeutics
Rondo Therapeutics
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T Non Small Cell Lung Cancer, Cervical Cancer, Head and Neck Squamous Cell Cancer | Phase 1 | 2025-11-17 |